Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Dandiag A/S
A/S
Active
Advertising protection
CVR 20840382
Baldersbuen 24, 2640
Hedehusene
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1998 · 28 years old
43 employees
www.dandiag.dk
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Dandiag A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
39M
29M
19M
10M
0M
2021: 31M
31M
2021
2022: 25M (-19% vs 2021)
25M
-19%
2022
2023: 26M (+4% vs 2022)
26M
+4%
2023
2024: 21M (-19% vs 2023)
21M
-19%
2024
2025: 22M (+5% vs 2024)
22M
+5%
2025
EBITDA
DKK millions
19M
13M
6M
-1M
-7M
2021: 14M
14M
2021
2022: 6M (-57% vs 2021)
6M
-57%
2022
2023: 5M (-17% vs 2022)
5M
-17%
2023
2024: -2M (-140% vs 2023)
-2M
-140%
2024
2025: 0M (+100% vs 2024)
0M
+100%
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Gross profit
21.974
21.379
26.265
25.420
31.145
Staff expenses
-22.433
-22.892
-21.572
-19.773
-17.395
EBITDA
-459
-1.513
4.693
5.647
13.751
Depreciation & amort.
-705
-975
-871
-1.177
-1.166
EBIT
-1.164
-2.488
3.822
4.469
12.585
Net financials
-147
-133
49
-403
242
Profit before tax
-1.310
-2.621
3.870
4.066
12.827
Tax
-287
-575
855
897
2.823
Net profit
-1.024
-2.046
3.016
3.169
10.003
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
23.815
20.265
20.052
24.265
33.410
Equity
7.302
8.325
13.372
13.356
20.187
Long-term debt
680
23
16
15
15
Short-term debt
15.596
11.917
6.665
10.894
13.208
Total debt
16.276
11.940
6.681
10.909
13.223
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-2.1%
This company
2021
2025
Equity ratio
30.7%
This company
38.2%
Market median
This company
Market median
20% below market
2021
2025
Return on equity
-14.0%
This company
18.4%
Market median
This company
Market median
176% below market
2021
2025
Net profit margin (of gross profit)
-4.7%
This company
2021
2025
Asset turnover (of gross profit)
0.92×
This company
2021
2025
Debt / equity
2.26×
This company
0.62×
Market median
This company
Market median
265% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Dandiag A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
